Pertussis vaccines: where to now?

References

• Edwards KM, Decker MD. Pertussis vaccine. In: Vaccines. Plotkin AS, Orenstein WA (Eds). Saunders, Philadelphia, PA, USA 471–528 (2004).
   Google Scholar
• Cherry JD. Historical review of pertussis and the classical vaccine. J. Infect. Dis.74(Suppl. 3), S259–S263 (1996).
   Google Scholar
• Ntezayabo B, De Serres G, Duval B. Pertussis resurgence in Canada largely caused by a cohort effect. Pediatr. Infect. Dis. J.22(1), 22–27 (2003).
   PubMed Web of Science ®Google Scholar
• de Melker HE, Conyn-van Spaendonck MA, Rümke HC, van Wijngaarden JK, Mooi FR, Schellekens JF. Pertussis in The Netherlands: an outbreak despite high levels of immunization with whole-cell vaccine. Emerging Infect. Dis.3(2), 175–178 (1997).
   PubMed Web of Science ®Google Scholar
• Zhang L, Prietsch SO, Axelsson I, Halperin SA. Acellular vaccines for preventing whooping cough in children. Cochrane Database Syst. Rev.2011(1), CD001478 (2011).
   Google Scholar
• Pertussis surveillance in Sweden – 12 year report. October 1. 1997 until December 31. 2009. Smitttskiddsinstitutets rapportserie (2010).
   Google Scholar
• Cherry JD, Gornbein J, Heininger U, Stehr K. A search for serologic correlates of immunity to Bordetella pertussis cough illnesses. Vaccine16(20), 1901–1906 (1998).
   PubMed Web of Science ®Google Scholar
• Storsaeter J, Hallander HO, Gustafsson L, Olin P. Levels of anti-pertussis antibodies related to protection after household exposure to Bordetella pertussis. Vaccine16(20), 1907–1916 (1998).
   PubMed Web of Science ®Google Scholar
• World Health Organization. Pertussis vaccines: WHO position paper. Wkly Epidemiol. Rec.85(40), 385–400 (2010).
   PubMedGoogle Scholar
• McVernon J, Andrews N, Slack MP, Ramsay ME. Risk of vaccine failure after Haemophilus influenzae type b (Hib) combination vaccines with acellular pertussis. Lancet361(9368), 1521–1523 (2003).
   PubMed Web of Science ®Google Scholar
• Yih WK, Lett SM, des Vignes FN, Garrison KM, Sipe PL, Marchant CD. The increasing incidence of pertussis in Massachusetts adolescents and adults, 1989–1998. J. Infect. Dis.182(5), 1409–1416 (2000).
   PubMed Web of Science ®Google Scholar
• Hallander HO, Andersson M, Gustafsson L, Ljungman M, Netterlid E. Seroprevalence of pertussis antitoxin (anti-PT) in Sweden before and 10 years after the introduction of a universal childhood pertussis vaccination program. APMIS117(12), 912–922 (2009).
   PubMed Web of Science ®Google Scholar
• Edelman K, He Q, Mäkinen J et al. Immunity to pertussis 5 years after booster immunization during adolescence. Clin. Infect. Dis.44(10), 1271–1277 (2007).
   PubMedGoogle Scholar
• Zepp F, Knuf M, Habermehl P et al. Cell-mediated immunity after pertussis vaccination and after natural infection. Dev. Biol. Stand.89, 307–314 (1997).
   PubMedGoogle Scholar
• Guiso N, Njamkepo E, Vié le Sage F et al. Long-term humoral and cell-mediated immunity after acellular pertussis vaccination compares favourably with whole-cell vaccines 6 years after booster vaccination in the second year of life. Vaccine25(8), 1390–1397 (2007).
   PubMed Web of Science ®Google Scholar
• Wendelboe AM, Van Rie A, Salmaso S, Englund JA. Duration of immunity against pertussis after natural infection or vaccination. Pediatr. Infect. Dis. J.24(Suppl. 5), S58–S61 (2005).
   PubMedGoogle Scholar
• Stenger RM, Smits M, Kuipers B et al. Impaired long-term maintenance and function of Bordetella pertussis specific B cell memory. Vaccine28(40), 6637–6646 (2010).
   PubMedGoogle Scholar
• van Gent M, Bart MJ, van der Heide HGJ et al. SNP-based typing: a useful tool to study Bordetella pertussis populations. PLoS ONE6(5), e20340 (2011).
   Google Scholar
• Kallonen T, He Q. Bordetella pertussis strain variation and evolution postvaccination. Expert Rev. Vaccines8(7), 863–875 (2009).
   PubMed Web of Science ®Google Scholar
• Miller E, Vurdien JE, White JM. The epidemiology of pertussis in England and Wales. Commun. Dis. Rep. CDR Rev.2(13), R152–R154 (1992).
   Google Scholar
• Hallander HO, Advani A, Donnelly D, Gustafsson L, Carlsson R-M. Shifts of Bordetella pertussis variants in Sweden from 1970 to 2003, during three periods marked by different vaccination programs. J. Clin. Microbiol.43(6), 2856–2865 (2005).
   PubMed Web of Science ®Google Scholar
• Poolman JT, Hallander HO. Acellular pertussis vaccines and the role of pertactin and fimbriae. Expert Rev. Vaccines6(1), 47–56 (2007).
   PubMed Web of Science ®Google Scholar
• van Loo IHM, Heuvelman KJ, King AJ, Mooi FR. Multilocus sequence typing of Bordetella pertussis based on surface protein genes. J. Clin. Microbiol.40(6), 1994–2001 (2002).
   PubMed Web of Science ®Google Scholar
• Packard ER, Parton R, Coote JG, Fry NK. Sequence variation and conservation in virulence-related genes of Bordetella pertussis isolates from the UK. J. Med. Microbiol.53(Pt 5), 355–365 (2004).
   PubMed Web of Science ®Google Scholar
• Advani A, Gustafsson L, Ahrén C, Mooi FR, Hallander HO. Appearance of Fim3 and ptxP3-Bordetella pertussis strains, in two regions of Sweden with different vaccination programs. Vaccine29(18), 3438–3442 (2011).
   PubMedGoogle Scholar
• Mooi FR, van Oirschot H, Heuvelman K, van der Heide HG, Gaastra W, Willems RJ. Polymorphism in the Bordetella pertussis virulence factors P.69/pertactin and pertussis toxin in The Netherlands: temporal trends and evidence for vaccine-driven evolution. Infect. Immun.66(2), 670–675 (1998).
   PubMed Web of Science ®Google Scholar
• van Amersfoorth SCM, Schouls LM, van der Heide HGJ et al. Analysis of Bordetella pertussis populations in European countries with different vaccination policies. J. Clin. Microbiol.43(6), 2837–2843 (2005).
   PubMed Web of Science ®Google Scholar
• Godfroid F, Denoël P, Poolman J. Are vaccination programs and isolate polymorphism linked to pertussis re-emergence? Expert Rev. Vaccines4(5), 757–778 (2005).
   PubMed Web of Science ®Google Scholar
• Visser HK. Health Council of the Netherlands advisory report ‘Vaccination against pertussis’ – time for a new vaccine. Ned Tijdschr Geneeskd.148(19), 916–918 (2004).
   PubMedGoogle Scholar
• Godfroid F, Denoël P, de Grave D, Schuerman L, Poolman J. Diphtheria-tetanus-pertussis (DTP) combination vaccines and evaluation of pertussis immune responses. Int. J. Med. Microbiol.294(5), 269–276 (2004).
   PubMed Web of Science ®Google Scholar
• Storsaeter J, Wolter J. Is there a need for a new generation of vaccines against pertussis? Expert Opin. Emerg. Drugs11(2), 195–205 (2006).
   PubMedGoogle Scholar
• Feunou PF, Kammoun H, Debrie A-S, Mielcarek N, Locht C. Long-term immunity against pertussis induced by a single nasal administration of live attenuated B. pertussis BPZE1. Vaccine28(43), 7047–7053 (2010).
   PubMed Web of Science ®Google Scholar